VR Logo

Pharming Group N.V. ADS each representing 10 (PHAR) download report


Healthcare | Biotechnology & Pharma Research

Pharming Group N.V. ADS each representing 10 (PHAR) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally.

IPO Date: 23-Dec-2020

Pres, CEO & Exec. Director: Dr. Sijmen de Vries M.B.A., M.D., MBA

Consultant: Dr. Bruno M. L. Giannetti

Listing: NASDAQ: PHAR

Country: Netherlands

Headquarters: Leiden,

Website: https://www.pharming.com

Key Facts

Market cap: $506.02 Mln

Revenue (TTM): $178.26 Mln

Earnings (TTM): $9.90 Mln

Cash: $189.67 Mln

Total Debt: $157.79 Mln

Insider's Holding: 0.00%

Liquidity: Low

52 Week range: $6.10 - 11.60

Shares outstanding: 64,874,900

5 Years Aggregate:

  • CFO: $251.02 Mln
  • EBITDA: $109.54 Mln
  • Net Profit: $27.75 Mln

Stock Performance

Time Period Pharming Group N.V. ADS each representing 10 (PHAR) S&P BSE Sensex* S&P Small-Cap 600*
YTD-15.55-8.99-19.22
1 month-8.26-3.40-9.34
3 months-9.04-8.50-14.58
1 Year-34.260.89-17.64
3 Years--10.415.91
5 Years--11.435.64
10 Years--11.7710.10
As on 29-Jun-2022 *As on 30-Jun-2022
Year Pharming Group N.V. ADS each representing 10 (PHAR) S&P Small-Cap 600 S&P BSE Sensex
2021-41.1625.2721.99